Status:
COMPLETED
Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy
Lead Sponsor:
Hacettepe University
Conditions:
Duchenne Muscular Dystrophy
Gait Disorders in Children
Eligibility:
MALE
5-18 years
Phase:
NA
Brief Summary
The aim of this study was to develop a gait assessment instrument for Duchenne Muscular Dystrophy patients (DMD-GAS), and investigate its validity and reliability.The scale was developed considering t...
Eligibility Criteria
Inclusion
- Being diagnosed with DMD
- Be between Levels I-V according to Brooke Lower Limb Extremity Functional Classification
- Being between the ages of 5-18
- Agreeing to participate in the research voluntarily
Exclusion
- Insufficient cooperation with the physiotherapist,
- Have had any injury and/or surgery of the lower extremities in the last 6 months,
- Having neurological problems in addition to DMD. -
Key Trial Info
Start Date :
February 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2022
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05244395
Start Date
February 10 2020
End Date
February 10 2022
Last Update
March 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Sıhhiye, Turkey (Türkiye), 06100